March 3 2025 - AbbVie pays Gubra $350M to make late play for obesity space

AbbVie pays Gubra $350M to make late play for obesity space
FDA recall notice details J&J pause of Varipulse
RFK Jr. move to kill public comment roils providers
GSK bows to Trump pressure and pauses diversity policies
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud